Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF

Abstract

Natalizumab impacts B and T cell distribution and exerts an inhibitory effect on surrogates of B cell function in periphery and in cerebrospinal fluid, potentially contributing to the increased risk of developing PML.